| 702 |
Expert Opinion for IVUS Use in Practice (Several IVUS Registry and PROSPECT Trial) |
Akiko Maehara |
May. 04. 10 |
| 701 |
Practice Guideline for FFR Use (FAME Study) |
William F. Fearon |
May. 04. 10 |
| 700 |
PCI in Chronic Kidney Disease (RECOVER, CARE, LOCM-Related Studies, and Meta-Analysis) |
Roxana Mehran |
May. 04. 10 |
| 699 |
Revascularization Strategies (SYNTAX, BARI-2D, and STICH) |
David R. Holmes |
May. 04. 10 |
| 698 |
Stents Use in STEMI (Massachusetts Registry, NewYork Registry, Small Registries, HORIZONS-AMI, DEBATER, and GENIUS-STEMI) |
Donald E. Cutlip |
May. 04. 10 |
| 697 |
Triage and Transfer for PCI in STEMI (ASSENT-4, FINESSE, CARESS-in-AMI, TRANSFER-AMI, and Several Regional Systems of STEMI Care |
Christian M. Spaulding |
May. 04. 10 |
| 696 |
Risk-Reduction Drugs: Statin or Others (NAPLES II Trial, ARMYDA-RECAPTURE, and Other Drug-Trial Beyond Antiplatelets or Anticoagulants in ACS ) |
Anthony H. Gershlick |
May. 04. 10 |
| 695 |
Timing of Antiplatelet Therapy for ACS (EARLY-ACS, and ACUITY) |
Mitchell W. Krucoff |
May. 04. 10 |
| 694 |
Timing of Angiography (Early Invasive vs. Conservative) for High-Risk ACS; (TIMACS, ISAR-COOL, and ABOARD) |
Christian M. Spaulding |
May. 04. 10 |
| 693 |
New Thienopyridine Use in ACS and PCI (TRITON-TIMI 38 and Several Subgroup Analyses, PLATO and Several Subgroup Analyses, and CHAMPION Trials) |
David Joel Cohen |
May. 04. 10 |
